Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Charles Parish

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Skinmed|October 21, 2024
Editors and Journals: Part III-"<i>Sto Tavo</i> (Who Is In Charge)?"W Clark Lambert, Lawrence Charles Parish, Philip R Cohen, et al.
American Journal of Clinical Dermatology|September 5, 2020
Antibiotic Resistance in Acne: Mechanisms, Complications and ManagementMelek Aslan Kayiran, Ayse Serap Karadag, Safaa Al-Khuzaei, et al.
Skinmed|December 4, 2021
The Essential Role of Dermatology Publications in Enhancing Professional Diversity, Equity, and InclusionSusan Burgin, Ncoza C Dlova, John R Ingram, et al.
Skinmed|July 12, 2012
Paget's disease of the breastJuliana Corrêa Marques-Costa, Tullia Cuzzi, Sueli Carneiro, et al.
Clinics in Dermatology|August 10, 2022
Dermatographism in popular cultureAriana Page Russell, Jeannine Hall Gailey, Boraan Abdulkarim, et al.
Clinics in Dermatology|July 9, 2023
Annular and acral/facial dyskeratotic paraneoplastic disordersRohan Shah, Thu Truong, Robert A Schwartz, et al.
Clinics in Dermatology|December 31, 2023
Eponyms and clinical entities from the land of IsraelLeonard J Hoenig, Sarah Brenner, Ronni Wolf, et al.
Journal of Drugs in Dermatology : JDD|November 5, 2011
A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedisLawrence Charles Parish, Jennifer L Parish, Hirak B Routh, et al.
Clinics in Dermatology|June 22, 2020
Blemished noses in the art of three masters: Ghirlandaio, Rembrandt, and WarholTaha Osman Mohammed, Shahzeb Hassan, Noor Hamideh, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trialLawrence Charles Parish, Joseph Lucius Jorizzo, John Jeffrey Breton, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Skinmed|October 21, 2024
Editors and Journals: Part III-"<i>Sto Tavo</i> (Who Is In Charge)?"W Clark Lambert, Lawrence Charles Parish, Philip R Cohen, et al.
American Journal of Clinical Dermatology|September 5, 2020
Antibiotic Resistance in Acne: Mechanisms, Complications and ManagementMelek Aslan Kayiran, Ayse Serap Karadag, Safaa Al-Khuzaei, et al.
Skinmed|December 4, 2021
The Essential Role of Dermatology Publications in Enhancing Professional Diversity, Equity, and InclusionSusan Burgin, Ncoza C Dlova, John R Ingram, et al.
Skinmed|July 12, 2012
Paget's disease of the breastJuliana Corrêa Marques-Costa, Tullia Cuzzi, Sueli Carneiro, et al.
Clinics in Dermatology|August 10, 2022
Dermatographism in popular cultureAriana Page Russell, Jeannine Hall Gailey, Boraan Abdulkarim, et al.
Clinics in Dermatology|July 9, 2023
Annular and acral/facial dyskeratotic paraneoplastic disordersRohan Shah, Thu Truong, Robert A Schwartz, et al.
Clinics in Dermatology|December 31, 2023
Eponyms and clinical entities from the land of IsraelLeonard J Hoenig, Sarah Brenner, Ronni Wolf, et al.
Journal of Drugs in Dermatology : JDD|November 5, 2011
A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedisLawrence Charles Parish, Jennifer L Parish, Hirak B Routh, et al.
Clinics in Dermatology|June 22, 2020
Blemished noses in the art of three masters: Ghirlandaio, Rembrandt, and WarholTaha Osman Mohammed, Shahzeb Hassan, Noor Hamideh, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trialLawrence Charles Parish, Joseph Lucius Jorizzo, John Jeffrey Breton, et al.
Pageof 11